PANACEA ACQUISITION CORP II's ticker is PANA and the CUSIP is G6882C106. A total of 50 filers reported holding PANACEA ACQUISITION CORP II in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $509 | +1.0% | 50,000 | 0.0% | 0.01% | -14.3% |
Q4 2022 | $504 | -99.9% | 50,000 | +0.0% | 0.01% | +40.0% |
Q3 2022 | $489,000 | +0.2% | 49,996 | -0.0% | 0.01% | 0.0% |
Q2 2022 | $488,000 | 0.0% | 50,000 | 0.0% | 0.01% | +66.7% |
Q1 2022 | $488,000 | +0.8% | 50,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $484,000 | -0.6% | 50,000 | -0.0% | 0.00% | 0.0% |
Q3 2021 | $487,000 | -3.6% | 50,024 | -1.0% | 0.00% | -40.0% |
Q2 2021 | $505,000 | – | 50,551 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RIT CAPITAL PARTNERS PLC | 900,000 | $8,775,000 | 3.42% |
MYDA Advisors LLC | 600,000 | $5,862,000 | 1.64% |
Consonance Capital Management LP | 200,000 | $1,953,000 | 1.07% |
Prosight Management, LP | 188,940 | $1,846,000 | 1.02% |
683 Capital Management, LLC | 1,480,000 | $14,460,000 | 0.56% |
Sage Rock Capital Management LP | 382,500 | $3,737,000 | 0.56% |
Bain Capital Life Sciences Investors, LLC | 500,000 | $4,885,000 | 0.30% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 898,856 | $8,764,000 | 0.23% |
Greenlight Capital | 275,000 | $2,687,000 | 0.18% |
Boxer Capital, LLC | 500,000 | $4,885,000 | 0.17% |